4512-0204

4512-0204 Nasal Naloxone Pilot Expansion

Spending Categories

Spending Category
FY2022 Expended
FY2023 Expended
FY2024 Expended
FY2025 Projected Spending
FY2026 House 1
Operating Expenses
517,060
625,207
1,140,480
1,150,000
1,242,000
Grants & Subsidies
480,912
0
25,000
106,718
56,718
Total
997,972
625,207
1,165,480
1,256,718
1,298,718
Loading...